Quarterly report pursuant to Section 13 or 15(d)

Related Party Matters (Details)

v3.22.1
Related Party Matters (Details)
3 Months Ended 4 Months Ended
Mar. 01, 2022
USD ($)
Feb. 28, 2022
USD ($)
Oct. 11, 2021
USD ($)
Dec. 19, 2019
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Apr. 30, 2021
agreement
Dec. 31, 2021
USD ($)
Related Party Transaction [Line Items]                
Prepaid expenses - related party         $ 48,908     $ 13,432
Research and development expense         1,265,653 $ 609,656    
Exclusive Sponsored Research Agreement | EHBE                
Related Party Transaction [Line Items]                
Initial term of research agreement (years)     1 year          
Prepaid expenses - related party         0     5,376
Annual retainer amount     $ 200,000          
Research and development expense         50,000      
Renewal term of research agreement     1 year          
Notice period for termination     60 days          
ESRA Agreement, Screening Platform For Anteroposterior Ocular Diseases                
Related Party Transaction [Line Items]                
Research and development expense         16,086      
ESRA Agreement, Screening Platform For Anteroposterior Ocular Diseases | EHBE                
Related Party Transaction [Line Items]                
Annual retainer amount $ 190,500              
Dr. Avtar Dhillon | Independent Contractor Agreement                
Related Party Transaction [Line Items]                
Fees incurred under agreement         30,000      
Accrued expense under agreement         39,018     69,600
Prepaid expenses - related party         48,908     $ 8,056
Dr. Avtar Dhillon | Independent Contractor Services Agreement                
Related Party Transaction [Line Items]                
Monthly fee       $ 10,000        
Related party expenses         0      
Fees incurred under agreement         $ 8,595      
Emerald Health Biotechnology Espana, S.L.U. | Collaborative Research Agreement                
Related Party Transaction [Line Items]                
Number of collaborative research agreements | agreement             2  
Initial term of research agreement (years)             1 year  
Termination terms, period following uncured breach (days)             45 days  
Emerald Health Biotechnology Espana, S.L.U. | Collaborative Research Agreement | Emerald Health Research, Inc                
Related Party Transaction [Line Items]                
Ownership percentage (percent)             100.00%  
Emerald Health Pharmaceuticals, Inc. | Sciences | Jim Heppell                
Related Party Transaction [Line Items]                
Ownership percentage (percent)         23.00%      
Emerald Health Pharmaceuticals, Inc. | Sciences | Punit Dhillon                
Related Party Transaction [Line Items]                
Ownership percentage (percent)         48.00%      
Immediate Family Member of Management or Principal Owner | Consulting Agreement                
Related Party Transaction [Line Items]                
Annual rate per hour   $ 78            
Termination notice period   15 days